{"DataElement":{"publicId":"3234467","version":"1","preferredName":"Lymph Node Post Neoadjuvant Therapy Response Code","preferredDefinition":"Text code to represent the result of neoadjuvant chemotherapy treatment on sites of disease in lymph node(s).","longName":"LN_NEOADJ_RESP_CD","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3234404","version":"1","preferredName":"Lymph Node Post Neoadjuvant Therapy Response","preferredDefinition":"information related to the evaulation or systematic appraisal of the lymph nodes located in the armpit that drains the lymphatic vessels that originate from the breast tissue following neoadjuvant therapy, reatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents._In medicine, an improvement related to treatment._A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body.","longName":"LN_NEOADJ_RESP","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2430092","version":"1","preferredName":"Lymph Node","preferredDefinition":"A rounded mass of lymphatic tissue that is surrounded by a capsule of connective tissue. Lymph glands filter lymph (lymphatic fluid), and they store lymphocytes (white blood cells). They are located along lymphatic vessels. Also called a lymph node.","longName":"C12745","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymph Node","conceptCode":"C12745","definition":"A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05B23066-8F9B-1D7B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-17","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-17","modifiedBy":"ONEDATA","dateModified":"2005-11-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3228223","version":"1","preferredName":"Post Neoadjuvant Therapy Response","preferredDefinition":"Post; occuring after.:Treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents. Induction therapy is followed by additional therapy to eliminate whatever cancer remains.:In medicine, an improvement related to treatment.","longName":"C38008:C15665:C50995","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Neoadjuvant Therapy","conceptCode":"C15665","definition":"Therapy administered prior to the primary treatment for the purpose of making the primary treatment more effective.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease Response","conceptCode":"C50995","definition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A147C0E5-778B-4A7D-E040-BB89AD432370","latestVersionIndicator":"Yes","beginDate":"2011-04-19","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-04-19","modifiedBy":"ONEDATA","dateModified":"2011-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008563","version":"1","preferredName":"Therapy Results","preferredDefinition":"the results or effects (does not include CTC Adverse Events) of therapeutic agents or procedures administered to the patient.","longName":"TX_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6690D31-4081-494A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-06","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-02-11","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2ED5D1E-5815-742B-E040-BB89AD4304FD","latestVersionIndicator":"Yes","beginDate":"2011-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-10","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3234458","version":"1","preferredName":"Lymph Node Post Neoadjuvant Therapy Response Code","preferredDefinition":"A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection._Post; occuring after._Treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents. Induction therapy is followed by additional therapy to eliminate whatever cancer remains._In medicine, an improvement related to treatment._A system of numbered categories for representation of data.","longName":"LN_NEOADJ_RESP_CD","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"L2","valueDescription":"Isolated tumor cell clusters","ValueMeaning":{"publicId":"3234461","version":"1","preferredName":"Isolated tumor cell clusters","longName":"3234461","preferredDefinition":"Isolated tumor cell clusters","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2F0C720-0D46-CE54-E040-BB89AD43681B","latestVersionIndicator":"Yes","beginDate":"2011-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A2F0C720-0D5F-CE54-E040-BB89AD43681B","beginDate":"2011-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-10","modifiedBy":"ONEDATA","dateModified":"2011-05-10","deletedIndicator":"No"},{"value":"L1","valueDescription":"No tumor in resected nodes","ValueMeaning":{"publicId":"3234462","version":"1","preferredName":"No tumor in resected nodes","longName":"3234462","preferredDefinition":"No tumor in resected nodes","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2F0C720-0D69-CE54-E040-BB89AD43681B","latestVersionIndicator":"Yes","beginDate":"2011-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A2F0C720-0D82-CE54-E040-BB89AD43681B","beginDate":"2011-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-10","modifiedBy":"ONEDATA","dateModified":"2011-05-10","deletedIndicator":"No"},{"value":"L0","valueDescription":"No nodes resected","ValueMeaning":{"publicId":"3234463","version":"1","preferredName":"No nodes resected","longName":"3234463","preferredDefinition":"No nodes resected","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2F0C720-0D8C-CE54-E040-BB89AD43681B","latestVersionIndicator":"Yes","beginDate":"2011-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A2F0C720-0DA5-CE54-E040-BB89AD43681B","beginDate":"2011-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-10","modifiedBy":"ONEDATA","dateModified":"2011-05-10","deletedIndicator":"No"},{"value":"L4","valueDescription":"One or more macromets","ValueMeaning":{"publicId":"3234459","version":"1","preferredName":"One or more macromets","longName":"3234459","preferredDefinition":"One or more macromets","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2F0C720-0D00-CE54-E040-BB89AD43681B","latestVersionIndicator":"Yes","beginDate":"2011-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A2F0C720-0D19-CE54-E040-BB89AD43681B","beginDate":"2011-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-10","modifiedBy":"ONEDATA","dateModified":"2011-05-10","deletedIndicator":"No"},{"value":"L3","valueDescription":"One or more micromets","ValueMeaning":{"publicId":"3234460","version":"1","preferredName":"One or more micromets","longName":"3234460","preferredDefinition":"One or more micromets","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2F0C720-0D23-CE54-E040-BB89AD43681B","latestVersionIndicator":"Yes","beginDate":"2011-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A2F0C720-0D3C-CE54-E040-BB89AD43681B","beginDate":"2011-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-10","modifiedBy":"ONEDATA","dateModified":"2011-05-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008563","version":"1","preferredName":"Therapy Results","preferredDefinition":"the results or effects (does not include CTC Adverse Events) of therapeutic agents or procedures administered to the patient.","longName":"TX_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6690D31-4081-494A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-06","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-02-11","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3234457","version":"1","preferredName":"Lymph Node Post Neoadjuvant Therapy Response Code","preferredDefinition":"A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.:Post; occuring after.:Treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents. Induction therapy is followed by additional therapy to eliminate whatever cancer remains.:In medicine, an improvement related to treatment.:A system of numbered categories for representation of data.","longName":"3234457v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymph Node","conceptCode":"C12745","definition":"A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Neoadjuvant Therapy","conceptCode":"C15665","definition":"Therapy administered prior to the primary treatment for the purpose of making the primary treatment more effective.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Disease Response","conceptCode":"C50995","definition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2F0C720-0CDC-CE54-E040-BB89AD43681B","latestVersionIndicator":"Yes","beginDate":"2011-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-10","modifiedBy":"ONEDATA","dateModified":"2011-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2F0C720-0CED-CE54-E040-BB89AD43681B","latestVersionIndicator":"Yes","beginDate":"2011-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-10","modifiedBy":"ONEDATA","dateModified":"2011-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2811715","version":"1","longName":"Duke University","context":"NCIP"},{"publicId":"2812724","version":"1","longName":"Duke U New CDEs","context":"NCIP"}]},{"publicId":"3886752","version":"1","longName":"For Review","context":"DCI","ClassificationSchemeItems":[{"publicId":"3891931","version":"1","longName":"For Review","context":"DCI"}]}],"AlternateNames":[{"name":"DCI","type":"USED_BY","context":"DCI"}],"ReferenceDocuments":[{"name":"Response in Lymph Node","type":"Preferred Question Text","description":"Response in Lymph Node","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2F0C720-0DED-CE54-E040-BB89AD43681B","latestVersionIndicator":"Yes","beginDate":"2011-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-10","modifiedBy":"ZHANGWE","dateModified":"2013-09-13","changeDescription":"Curated to support Duke University clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}